Molecular Diagnostics Global Market Will Attain A Phenomenal Growth By 2027; MRFR


Posted August 22, 2017 by magarjitendra

Global Molecular Diagnostics Market by technique types (polymerase chain reaction, spectral karyotype imaging) by application (diseases, oncology, pharmacogenomics, genetic disease screening) by end users - Forecast to 2027

 
Molecular Diagnostics Global Market - Overview
The Global Molecular Diagnostics Market is growing with the rapid pace; mainly due to the rising prevalence of infectious diseases. According to a recent study report published by the Market Research Future, The global market of Molecular Diagnostics is getting the momentum and is expected to gain prominence over the forecast period. The global Molecular Diagnostics market is forecasted to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the estimated period (2017 – 2027).
The Flourishing growth of Global Molecular Diagnostics Market is attributed to the rising prevalence infectious diseases, chronic diseases like cancer and prevailing adoption of personalized medicine and diagnostics. Additionally, growth prospects of pharmacogenomics as a vertical, Developments and advancements in the field of biomarker identification are some of the prominent factors that propels the market growth of Molecular Diagnostics. Moreover, advantageous rebating systems for medical expenditures in countries such as US along with the advent molecular techniques foster the market growth prospects.

Key Players for Molecular Diagnostics Market:
• Roche Diagnostics (Switzerland),
• Qiagen (Germany) (includes Digene),
• Becton, Dickinson and Company (US),
• Novartis (Switzerland),
• Abbott laboratories (US),
• Hologic (includes Gen-Probe) (US),
• Dako (Denmark).
• Cepheid (US),
• Beckman Coulter Inc. (U.S.),
• Siemens Healthineers (Germany),
• Others

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/1171

Inventions:
The MiSeqDx instrument is the first FDA-cleared in vitro diagnostic (IVD) next-generation sequencing (NGS) system. Designed specifically for the clinical laboratory environment, the MiSeqDx instrument is a desktop sequencer that incorporates an easy-to-follow workflow and an integrated software design to enable sample tracking, user traceability, and results interpretation. Built on proven Illumina sequencing by synthesis (SBS) chemistry, the MiSeqDx instrument provides accurate, reliable screening and diagnostic testing, providing the speed and accuracy to enrich human understanding of disease, enabling earlier detection and reducing the time to diagnosis. Illumina provides a growing menu of assays and kits enabling clinical laboratories to create and deploy NGS-based molecular diagnostic tests, including cystic fibrosis and a wide range of other applications.

Segments:
Global Molecular Diagnostics Market has been segmented
On the basis of applications which consist of infectious diseases, oncology, pharmacogenomics, genetic disease screening, human leukocyte antigen typing, and coagulation.
On the basis of technique type which includes polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), spectral karyotype imaging (SKI), and DNA chip technology.
On the basis of end users which includes Laboratories, Hospitals, Academic Institutes and others

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Molecular Diagnostics Market Research Report- Forecast To 2027”

Access Report Detail @ https://www.marketresearchfuture.com/reports/molecular-diagnostics-market

Molecular Diagnostics Global Market – Competitive Analysis
The Molecular Diagnostics market appears to be highly competitive and fragmented owing to the presence of several large and small key players accounting for a substantial market share. Marketers make substantial investments in R&D to develop technically advanced molecular techniques. Well established players incorporate acquisition, collaboration, partnership, and expansion with the increased focus on large commercial laboratories and hospitals in order to gain competitive advantage in this market and to maintain their market position. Expanding economies and growing affluence in China, India, and other countries of the Pacific Rim create additional opportunities for the Molecular Diagnostics market. Once considered as fringe market, some vendors now view this market as significant opportunities for market expansion. Eventually, a combination of technology innovations, patient education, and economic incentives may be needed to ominously expand the Molecular Diagnostics market and build sustainable long-term dollar growth for Molecular Diagnostics vendors. Advances in genomics and proteomics, increasing adoption of point-of-care testing, developing markets in Asia-Pacific such as China, India, Brazil, Mexico, and South Africa offer lucrative opportunities for players in the market.

Molecular Diagnostics Global Market - Regional Analysis
Globally North America is the largest market for Molecular Diagnostics Market. The North American market for Molecular Diagnostics Market is expected to grow at a substantial CAGR and is expected to reach to astronomical amounts by the end of the forecasted period. Europe is the second-largest market for Molecular Diagnostics Market which is expected to grow at a considerable CAGR.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Future
Country India
Categories Business , Health , Medical
Tags healthcare , molecular diagnostics , molecular diagnostics market , molecular diagnostics market research report
Last Updated August 22, 2017